Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8541123 | 0.88 | LMNA (0.36) | — | |
| SCHEMBL13308357 | 0.84 | — | — | |
| SCHEMBL15824082 | 0.78 | TSHR (0.32) | — | |
| SCHEMBL2303259 | 0.76 | ALDH1A1 (0.33) | — | |
| SCHEMBL19387334 | 0.75 | SMN1; SMN2 (0.44) | — | |
| SCHEMBL14537811 | 0.75 | — | — | |
| SCHEMBL13934056 | 0.74 | — | — | |
| SCHEMBL1647709 | 0.74 | ALOX15 (0.31) | ALOX15 | |
| SCHEMBL28850438 | 0.74 | SLC15A1 (0.32) | — | |
| SCHEMBL28221275 | 0.73 | PTGS1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12042557-B2 | Rapid establishment and/or termination of substantial steady-state drug delivery | I2O THERAPEUTICS, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| CN-107638562-B | Rapid establishment and/or termination of substantial steady-state drug delivery | 精达制药公司 | 2022-12-02 | — | — | CN | disclosed |
| US-20210236413-A1 | RAPID ESTABLISHMENT AND/OR TERMINATION OF SUBSTANTIAL STEADY-STATE DRUG DELIVERY | I2O THERAPEUTICS, INC. | 2021-08-05 | — | — | US | disclosed |
| US-10869830-B2 | Rapid establishment and/or termination of substantial steady-state drug delivery | INTARCIA THERAPEUTICS, INC. (US) | 2020-12-22 | — | — | US | disclosed |
| EP-3735944-A1 | RAPID ESTABLISHMENT AND/OR TERMINATION OF SUBSTANTIAL STEADY-STATE DRUG DELIVERY | Intarcia Therapeutics, Inc. (US) | 2020-11-11 | — | — | EP | disclosed |
| EP-1817008-B1 | STABILIZED HME COMPOSITION WITH SMALL DRUG PARTICLES | UNIV TEXAS (US) | 2020-04-01 | — | — | EP | disclosed |
| US-10441528-B2 | Devices, formulations, and methods for delivery of multiple beneficial agents | INTARCIA THERAPEUTICS, INC. (US) | 2019-10-15 | — | — | US | disclosed |
| US-10322209-B2 | Polyurethanes for osteoimplants | WARSAW ORTHOPEDIC, INC. (US) | 2019-06-18 | — | — | US | disclosed |
| US-20190105259-A1 | RAPID ESTABLISHMENT AND/OR TERMINATION OF SUBSTANTIAL STEADY-STATE DRUG DELIVERY | INTARCIA THERAPEUTICS, INC. | 2019-04-11 | — | — | US | disclosed |
| US-10231923-B2 | Rapid establishment and/or termination of substantial steady-state drug delivery | INTARCIA THERAPEUTICS, INC. (US) | 2019-03-19 | — | — | US | disclosed |
| US-3993072-A | Microporous drug delivery device | ALZA CORPORATION (US) | 1976-11-23 | — | — | US | disclosed |
| US-3993057-A | Intrauterine device that bioerodes in response to the environment of the uterus and method of using | ALZA CORPORATION (US) | 1976-11-23 | — | — | US | disclosed |
| US-3993073-A | Novel drug delivery device | ALZA CORPORATION (US) | 1976-11-23 | — | — | US | disclosed |
| US-3977404-A | OSMOTIC DEVICE HAVING MICROPOROUS RESERVOIR | ALZA CORPORATION (US) | 1976-08-31 | — | — | US | disclosed |
| US-3971367-A | Intrauterine device having means for changing from uterine-retentive shape to nonuterine-retentive shape | ALZA CORPORATION (US) | 1976-07-27 | — | — | US | disclosed |
| US-3967618-A | Drug delivery device | ALZA CORPORATION (US) | 1976-07-06 | — | — | US | disclosed |
| US-3964482-A | Drug delivery device | ALZA CORPORATION (US) | 1976-06-22 | — | — | US | disclosed |
| US-3948254-A | Novel drug delivery device | ALZA CORPORATION (US) | 1976-04-06 | — | — | US | disclosed |
| US-3948262-A | Novel drug delivery device | ALZA CORPORATION (US) | 1976-04-06 | — | — | US | disclosed |
| US-3944064-A | Self-monitored device for releasing agent at functional rate | ALZA CORPORATION (US) | 1976-03-16 | — | — | US | disclosed |